Daily Oncology News

ASCO Issues Statement Addressing Alcohol and Cancer

ASCO Issues Statement Addressing Alcohol and Cancer

Alcohol-related cancers account for 5.5 percent of all cancers treated annually worldwide.

Drug Combination Does Not Extend Glioblastoma Survival

Drug Combination Does Not Extend Glioblastoma Survival

Lomustine plus bevacizumab may increase progression-free, but not overall, survival versus lomustine alone in progressive glioblastoma.

Breast Cancer Recurrences Steady Following Therapy Cessation

Breast Cancer Recurrences Steady Following Therapy Cessation

Women with ER-positive BC who stop therapy after 5 years have steady recurrence rate up to 20 years afterward.

PPI-Gastric Cancer Link Remains After H. Pylori Eradication

PPI-Gastric Cancer Link Remains After H. Pylori Eradication

Increased risk seen in H. pylori-infected subjects who received eradication therapy

Fiber Associated With Reduced Mortality in Those With Colorectal Cancer

Fiber Associated With Reduced Mortality in Those With Colorectal Cancer

Increasing fiber consumption after diagnosis may lower risk of all-cause, CRC-specific mortality.

70-Gene Signature Assay Impacts Treatment Decisions in Breast Cancer

70-Gene Signature Assay Impacts Treatment Decisions in Breast Cancer

The 70-GS was linked to change in treatment decisions for intermediate-risk patients based on 21-gene assay.

Acalabrutinib Approved for Mantle Cell Lymphoma

Acalabrutinib Approved for Mantle Cell Lymphoma

Acalabrutinib is a treatment option for patients with mantle cell lymphoma who have not responded to prior treatment.

Flow Cytometry Assesses Minimal Residual Disease in Multiple Myeloma

Flow Cytometry Assesses Minimal Residual Disease in Multiple Myeloma

The use of flow cytometry has demonstrated usefulness in multiple myeloma recurrence assessment.

Provider Advice Affects Breast Cancer Prevention Decisions

Provider Advice Affects Breast Cancer Prevention Decisions

The recommendation of an HCP is a key factor in the decision to employ selective estrogen receptor modulators (SERMs) for patients at higher risk for breast cancer.

Cryotherapy May Help Prevent Chemo-Induced Neuropathy

Cryotherapy May Help Prevent Chemo-Induced Neuropathy

Breast cancer patients on paclitaxel had lower incidence of peripheral neuropathy with cryotherapy, researchers found.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs